Tag: BPAX

APP, BPAX – Today’s Stocks

American Apparel, Inc. APP

APP ran into a patch of resistance at .75 this past Friday, and once again this week. It seems that this level is going to be a major hurdle for us to get over, but following a breakthrough, there appears to be relatively little resistance until around .85.

Looking forward a bit, it is going to be very interesting when the quarterly numbers for this retailer’s holiday season come in. This stock will be on our watchlist at least until that time.

BioSante Pharmaceuticals, Inc. BPAX

BPAX saw its first breath of life coming off of its bottom yesterday, as we are now starting to see signs of recovery. Yesterday was the stock’s first green session since it fell off of a cliff of late, but we are now seeing accumulation at this low level, which excites us with the possibility that a snap of gains may be forthcoming.

The trouble started for BPAX after a less-than-favorable testing outcome for one of the company’s products, Libigel. The ground may still be a little shaky with this play, but the bottom-line? We want to be around when this stock’s recovery reaches full-swing.

APP, BPAX, GRDO – Today’s Stocks

American Apparel, Inc. APP

APP hit a high of of .75 on Friday before closing strong at .72, bringing our total gains on this play to roughly 50%

There was also news out this morning:

LOS ANGELES, Dec. 19, 2011 /PRNewswire via COMTEX/ — American Apparel (Amex: APP), the vertically integrated clothing manufacturer based in downtown Los Angeles, announces the opening of two more shop-in-shops inside Selfridges, one of London’s most famous and respected department stores. The new locations in Manchester and Birmingham follow the ongoing success of the American Apparel concession at Selfridges, London which opened in 2010.

BioSante Pharmaceuticals, Inc. BPAX

BPAX showed up on our radar Friday, as we stated that we were observing diligently for a bottom to form following a serious dive that still seems to have some downward momentum.

The key here will still be the timing of the upswing, which often takes patience in these instances. We aren’t getting trigger-happy yet, as we know that these things take time, and the payoff can be more than worth the wait.

Guard Dog, Inc. GRDO

We mentioned last week that we’d like to see the support hold at .0006, which it did. We are looking to break a barrier of resistance at .0009 for it to then contest the highs it saw this past summer.

EXTO, AGDY, APP, BPAX – Today’s Stocks

Exit Only, Inc. EXTO

EXTO has seen two consecutive days of gains. The RSI is creeping up, as the MACD has begun to diverge following its recent cross.

We are seeing a volume increase here as the chart begins to shape up quite nicely. This has been the stock that has brought us the most opportunities to profit in 2011, and at the rate we’re going, the same could hold true in 2012.

Agri-Dynamics, Inc. AGDY

AGDY was a fast moving momentum play, that caught our eye because of its heavy volume. Once the excitement settles and the momentum of the surge dies down, we will be anxious to see where AGDY finds its base.

The stock was under a penny at the time of our alert, .009 to be exact, and ended up hitting an intraday high yesterday of .02., for a lightning quick gain of more than 100%

American Apparel, Inc. APP

APP hit a high of .68 after being as low as .52 following our alert earlier this week. This represents a gain of around 30% for this retail play.

We mentioned that it is not uncommon to see stocks in this sector enjoy increased activity at holiday time, due to a frenzied shopping season.

BioSante Pharmaceuticals, Inc. BPAX

BPAX is a bottom alert this morning. The stock fell off of a cliff yesterday following news that one of its highly anticipated products, Libigel, did not meet expectations in the latest round of testing.

We always like to play the role of bottom-feeder when stocks like this take a major dive, as profits are made in the resultant recovery period. We are going to want to watch this one diligently to identify the bottom, and adjust our entry strategy accordingly.